Bioteem40
Commercial- Indications
- Nutritional deficiency
Company intelligence / Profile preview
TheraPBios PHARMA is an active Canadian consumer healthcare/nutritional supplement company based in Windsor, Nova Scotia. Founded by medtech entrepreneur Abdullah Kirumira and COO Glyn Davies in late-2021, the company develops and sells the Bioteem40 line—liquid probiotic/prebiotic-based nutritional supplements that also include bioactive compounds like collagen and biotin for skin or immune support. Their business model focuses on combining these elements to enhance nutrient absorption through improved gut health.
The company's products are available throughout Atlantic Canada via retail partners such as Simply For Life as well as online nationally following Health Canada approval. TheraPBios manufactures its own products locally at its Windsor facility.
The firm has raised over $1 million CAD through non-dilutive funding sources previously and is currently closing additional private investment rounds to fund national expansion within Canada before targeting the U.S., pending FDA clearance.
No evidence was found that TheraPBios operates a traditional biotech/pharma R&D pipeline or platform technology beyond their proprietary formulation approach for consumer supplements. There are no public signs of acquisition activity or major pharmaceutical partnerships at this time[1][2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TheraPBios PHARMA.